BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yin R, Liu J, Zhao D, Wang F. Long Non-Coding RNA ASB16-AS1 Functions as a miR-760 Sponge to Facilitate the Malignant Phenotype of Osteosarcoma by Increasing HDGF Expression. Onco Targets Ther 2020;13:2261-74. [PMID: 32214826 DOI: 10.2147/OTT.S240022] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Luo J, Zhang XP, Zheng YY, Ma AH. Long non-coding RNA ASB16-AS1 inhibits proliferation, migration, and invasion of gastric cancer cells by regulating miR-670-3p/ATXN7L3 axis. Shijie Huaren Xiaohua Zazhi 2020; 28(15): 673-682 [DOI: 10.11569/wcjd.v28.i15.673] [Reference Citation Analysis]
2 Enomoto H, Nakamura H, Nishikawa H, Nishiguchi S, Iijima H. Hepatoma-Derived Growth Factor: An Overview and Its Role as a Potential Therapeutic Target Molecule for Digestive Malignancies. Int J Mol Sci 2020;21:E4216. [PMID: 32545762 DOI: 10.3390/ijms21124216] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Liu W, Wang D, Liu L, Wang L, Yan M. miR-140 inhibits osteosarcoma progression by impairing USP22-mediated LSD1 stabilization and promoting p21 expression. Mol Ther Nucleic Acids 2021;24:436-48. [PMID: 33868787 DOI: 10.1016/j.omtn.2021.01.029] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Long B, Yang X, Xu X, Li X, Xu X, Zhang X, Zhang S. Long noncoding RNA ASB16-AS1 inhibits adrenocortical carcinoma cell growth by promoting ubiquitination of RNA-binding protein HuR. Cell Death Dis 2020;11:995. [PMID: 33219221 DOI: 10.1038/s41419-020-03205-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
5 Yu M, Shi C, Xu D, Lin X, Ji T, Shi Z, Zhuge X, Zhuo S, Yang Q. LncRNA ASB16-AS1 drives proliferation, migration, and invasion of colorectal cancer cells through regulating miR-185-5p/TEAD1 axis. Cell Cycle 2021;:1-11. [PMID: 34870557 DOI: 10.1080/15384101.2021.1973700] [Reference Citation Analysis]
6 Yuan J, Liu Y, Zhang Q, Ren Z, Li G, Tian R. CircPRDM2 Contributes to Doxorubicin Resistance of Osteosarcoma by Elevating EZH2 via Sponging miR-760. Cancer Manag Res 2021;13:4433-45. [PMID: 34103997 DOI: 10.2147/CMAR.S295147] [Reference Citation Analysis]
7 Enomoto H, Nakamura H, Nishikawa H, Nishimura T, Iwata Y, Nishiguchi S, Iijima H. Hepatocellular Carcinoma-associated microRNAs Induced by Hepatoma-derived Growth Factor Stimulation. In Vivo 2020;34:2297-301. [PMID: 32871753 DOI: 10.21873/invivo.12041] [Reference Citation Analysis]
8 Wu L, Liao W, Wang X, Zhao Y, Pang J, Chen Y, Yang H, He Y. Expression, prognosis value, and immune infiltration of lncRNA ASB16-AS1 identified by pan-cancer analysis. Bioengineered 2021. [PMID: 34709970 DOI: 10.1080/21655979.2021.1996054] [Reference Citation Analysis]
9 Guo J, Yi X, Ji Z, Yao M, Yang Y, Song W, Huang M. Development of a Prognostic Model Based on the Identification of EMT-Related lncRNAs in Triple-Negative Breast Cancer. J Oncol 2021;2021:9219961. [PMID: 34873403 DOI: 10.1155/2021/9219961] [Reference Citation Analysis]